Global Renal Diseases Drug Industry Research Report 2020, Forecast to 2025

August 2020 | 102 pages | ID: G8B066973156EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Renal Diseases Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Renal Diseases Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Renal Diseases Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Renal Diseases Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Renal Diseases Drug market are discussed.

The market is segmented by types:

• Chronic Kidney Disease (CKD) Drugs
• End-Stage Kidney Disease (ESRD) Drugs

It can be also divided by applications:

• Hospitals
• Specialty Clinics
• Other

And this report covers the historical situation, present status and the future prospects of the global Renal Diseases Drug market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Pfizer
• AstraZeneca
• GlaxoSmithKline (GSK)
• Amgen
• Kissei Pharmaceutical
• Roche
• Sanofi
• AbbVie
• Allergan
• FibroGen
• Teva Pharmaceutical Industries
• Johnson & Johnson
• Keryx Biopharmaceuticals

Report Includes:

• xx data tables and xx additional tables
• An overview of global Renal Diseases Drug market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Renal Diseases Drug market
• Profiles of major players in the industry, including Pfizer, AstraZeneca, GlaxoSmithKline (GSK), Amgen, Kissei Pharmaceutical.....

Research Objectives

• To study and analyze the global Renal Diseases Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Renal Diseases Drug market by identifying its various subsegments.
• Focuses on the key global Renal Diseases Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Renal Diseases Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Renal Diseases Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Renal Diseases Drug Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Renal Diseases Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 RENAL DISEASES DRUG INDUSTRY OVERVIEW

2.1 Global Renal Diseases Drug Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Renal Diseases Drug Global Import Market Analysis
  2.1.2 Renal Diseases Drug Global Export Market Analysis
  2.1.3 Renal Diseases Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Chronic Kidney Disease (CKD) Drugs
  2.2.2 End-Stage Kidney Disease (ESRD) Drugs
2.3 Market Analysis by Application
  2.3.1 Hospitals
  2.3.2 Specialty Clinics
  2.3.3 Other
2.4 Global Renal Diseases Drug Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Renal Diseases Drug Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Renal Diseases Drug Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Renal Diseases Drug Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Renal Diseases Drug Manufacturer Market Share
  2.4.5 Top 10 Renal Diseases Drug Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Renal Diseases Drug Market
  2.4.7 Key Manufacturers Renal Diseases Drug Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Renal Diseases Drug Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Renal Diseases Drug Industry Impact
  2.7.1 How the Covid-19 is Affecting the Renal Diseases Drug Industry
  2.7.2 Renal Diseases Drug Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Renal Diseases Drug Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Renal Diseases Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL RENAL DISEASES DRUG MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Renal Diseases Drug Sales Market Share by Region
4.2 Global Renal Diseases Drug Revenue Market Share by Region (2015-2019)
4.3 Global Renal Diseases Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Renal Diseases Drug Market Size Detail
  4.4.1 North America Renal Diseases Drug Sales Growth Rate (2015-2020)
  4.4.2 North America Renal Diseases Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Renal Diseases Drug Market Size Detail
  4.5.1 Europe Renal Diseases Drug Sales Growth Rate (2015-2020)
  4.5.2 Europe Renal Diseases Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Renal Diseases Drug Market Size Detail
  4.6.1 Japan Renal Diseases Drug Sales Growth Rate (2015-2020)
  4.6.2 Japan Renal Diseases Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Renal Diseases Drug Market Size Detail
  4.7.1 China Renal Diseases Drug Sales Growth Rate (2015-2020)
  4.7.2 China Renal Diseases Drug Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL RENAL DISEASES DRUG MARKET SEGMENT BY TYPE

5.1 Global Renal Diseases Drug Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Renal Diseases Drug Sales and Market Share by Type (2015-2020)
  5.1.2 Global Renal Diseases Drug Revenue and Market Share by Type (2015-2020)
5.2 Chronic Kidney Disease (CKD) Drugs Sales Growth Rate and Price
  5.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020)
  5.2.2 Global Chronic Kidney Disease (CKD) Drugs Price (2015-2020)
5.3 End-Stage Kidney Disease (ESRD) Drugs Sales Growth Rate and Price
  5.3.1 Global End-Stage Kidney Disease (ESRD) Drugs Sales Growth Rate (2015-2020)
  5.3.2 Global End-Stage Kidney Disease (ESRD) Drugs Price (2015-2020)

6 GLOBAL RENAL DISEASES DRUG MARKET SEGMENT BY APPLICATION

6.1 Global Renal Diseases DrugSales Market Share by Application (2015-2020)
6.2 Hospitals Sales Growth Rate (2015-2020)
6.3 Specialty Clinics Sales Growth Rate (2015-2020)
6.4 Other Sales Growth Rate (2015-2020)

7 GLOBAL RENAL DISEASES DRUG MARKET FORECAST

7.1 Global Renal Diseases Drug Sales, Revenue Forecast
  7.1.1 Global Renal Diseases Drug Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Renal Diseases Drug Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Renal Diseases Drug Price and Trend Forecast (2020-2025)
7.2 Global Renal Diseases Drug Sales Forecast by Region (2020-2025)
  7.2.1 North America Renal Diseases Drug Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Renal Diseases Drug Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Renal Diseases Drug Production, Revenue Forecast (2020-2025)
  7.2.4 China Renal Diseases Drug Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF RENAL DISEASES DRUG INDUSTRY KEY MANUFACTURERS

8.1 Pfizer
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Pfizer Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Pfizer News
8.2 AstraZeneca
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 AstraZeneca Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 AstraZeneca News
8.3 GlaxoSmithKline (GSK)
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 GlaxoSmithKline (GSK) Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 GlaxoSmithKline (GSK) News
8.4 Amgen
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Amgen Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Amgen News
8.5 Kissei Pharmaceutical
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Kissei Pharmaceutical Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Kissei Pharmaceutical News
8.6 Roche
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Roche Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Roche News
8.7 Sanofi
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Sanofi Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Sanofi News
8.8 AbbVie
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 AbbVie Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 AbbVie News
8.9 Allergan
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Allergan Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Allergan News
8.10 FibroGen
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 FibroGen Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 FibroGen News
8.11 Teva Pharmaceutical Industries
  8.11.1 Company Details
  8.11.2 Product Information
  8.11.3 Teva Pharmaceutical Industries Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.11.4 Main Business Overview
  8.11.5 Teva Pharmaceutical Industries News
8.12 Johnson & Johnson
  8.12.1 Company Details
  8.12.2 Product Information
  8.12.3 Johnson & Johnson Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.12.4 Main Business Overview
  8.12.5 Johnson & Johnson News
8.13 Keryx Biopharmaceuticals
  8.13.1 Company Details
  8.13.2 Product Information
  8.13.3 Keryx Biopharmaceuticals Renal Diseases Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.13.4 Main Business Overview
  8.13.5 Keryx Biopharmaceuticals News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Renal Diseases Drug Picture
Figure Research Programs/Design for This Report
Figure Global Renal Diseases Drug Market by Regions (2019)
Table Global Market Renal Diseases Drug Comparison by Regions (M USD) 2019-2025
Table Global Renal Diseases Drug Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Renal Diseases Drug by Type in 2019
Figure Chronic Kidney Disease (CKD) Drugs Picture
Figure End-Stage Kidney Disease (ESRD) Drugs Picture
Table Global Renal Diseases Drug Sales by Application (2019-2025)
Figure Global Renal Diseases Drug Sales Market Share by Application in 2019
Figure Hospitals Picture
Figure Specialty Clinics Picture
Figure Other Picture
Table Global Renal Diseases Drug Sales by Manufacturer (2018-2020)
Figure Global Renal Diseases Drug Sales Market Share by Manufacturer in 2019
Table Global Renal Diseases Drug Revenue by Manufacturer (2018-2020)
Figure Global Renal Diseases Drug Revenue Market Share by Manufacturer in 2019
Table Global Renal Diseases Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Renal Diseases Drug Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Renal Diseases Drug Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Renal Diseases Drug Market
Table Key Manufacturers Renal Diseases Drug Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Renal Diseases Drug
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Renal Diseases Drug Sales (K Units) by Region (2015-2020)
Table Global Renal Diseases Drug Sales Market Share by Region (2015-2019)
Figure Global Renal Diseases Drug Sales Market Share by Region (2015-2019)
Figure Global Renal Diseases Drug Sales Market Share by Region in 2018
Table Global Renal Diseases Drug Revenue (Million US$) by Region (2015-2020)
Table Global Renal Diseases Drug Revenue Market Share by Region (2015-2020)
Figure Global Renal Diseases Drug Revenue Market Share by Region (2015-2020)
Figure Global Renal Diseases Drug Revenue Market Share by Region in 2019
Table Global Renal Diseases Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Renal Diseases Drug Sales (K Units) Growth Rate (2015-2020)
Table North America Renal Diseases Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Renal Diseases Drug Sales (K Units) Growth Rate (2015-2020)
Table Europe Renal Diseases Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Renal Diseases Drug Sales (K Units) Growth Rate (2015-2020)
Table Japan Renal Diseases Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Renal Diseases Drug Sales (K Units) Growth Rate (2015-2020)
Table China Renal Diseases Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Renal Diseases Drug Sales by Type (2015-2020)
Table Global Renal Diseases Drug Sales Market Share by Type (2015-2020)
Figure Global Renal Diseases Drug Sales Market Share by Type in 2019
Table Global Renal Diseases Drug Revenue by Type (2015-2020)
Table Global Renal Diseases Drug Revenue Market Share by Type (2015-2020)
Figure Global Renal Diseases Drug Revenue Market Share by Type in 2019
Figure Global Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drugs Price (2015-2020)
Figure Global End-Stage Kidney Disease (ESRD) Drugs Sales Growth Rate (2015-2020)
Figure Global End-Stage Kidney Disease (ESRD) Drugs Price (2015-2020)
Table Global Renal Diseases Drug Sales by Application (2015-2020)
Table Global Renal Diseases Drug Sales Market Share by Application (2015-2020)
Figure Global Renal Diseases Drug Sales Market Share by Application in 2019
Figure Global Hospitals Sales Growth Rate (2015-2020)
Figure Global Specialty Clinics Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Renal Diseases Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Renal Diseases Drug Price and Trend Forecast (2020-2025)
Table Global Renal Diseases Drug Sales (K Units) Forecast by Region (2020-2025)
Figure Global Renal Diseases Drug Production Market Share Forecast by Region (2020-2025)
Figure North America Renal Diseases Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Renal Diseases Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Renal Diseases Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Renal Diseases Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Renal Diseases Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Pfizer Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Pfizer
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Renal Diseases Drug Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table AstraZeneca Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of AstraZeneca
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Renal Diseases Drug Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table GlaxoSmithKline (GSK) Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of GlaxoSmithKline (GSK)
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure GlaxoSmithKline (GSK) Renal Diseases Drug Market Share (2018-2020)
Table GlaxoSmithKline (GSK) Main Business
Table GlaxoSmithKline (GSK) Recent Development
Table Amgen Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Amgen
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Amgen Renal Diseases Drug Market Share (2018-2020)
Table Amgen Main Business
Table Amgen Recent Development
Table Kissei Pharmaceutical Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Kissei Pharmaceutical
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Kissei Pharmaceutical Renal Diseases Drug Market Share (2018-2020)
Table Kissei Pharmaceutical Main Business
Table Kissei Pharmaceutical Recent Development
Table Roche Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Roche
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche Renal Diseases Drug Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table Sanofi Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Sanofi
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sanofi Renal Diseases Drug Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table AbbVie Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of AbbVie
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure AbbVie Renal Diseases Drug Market Share (2018-2020)
Table AbbVie Main Business
Table AbbVie Recent Development
Table Allergan Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Allergan
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Allergan Renal Diseases Drug Market Share (2018-2020)
Table Allergan Main Business
Table Allergan Recent Development
Table FibroGen Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of FibroGen
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure FibroGen Renal Diseases Drug Market Share (2018-2020)
Table FibroGen Main Business
Table FibroGen Recent Development
Table Teva Pharmaceutical Industries Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Teva Pharmaceutical Industries
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Pharmaceutical Industries Renal Diseases Drug Market Share (2018-2020)
Table Teva Pharmaceutical Industries Main Business
Table Teva Pharmaceutical Industries Recent Development
Table Johnson & Johnson Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Johnson & Johnson
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson Renal Diseases Drug Market Share (2018-2020)
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Keryx Biopharmaceuticals Company Profile
Figure Renal Diseases Drug Product Picture and Specifications of Keryx Biopharmaceuticals
Table Renal Diseases Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Keryx Biopharmaceuticals Renal Diseases Drug Market Share (2018-2020)
Table Keryx Biopharmaceuticals Main Business
Table Keryx Biopharmaceuticals Recent Development
Table of Appendix